Description  Claims  Drawing  Cited references 

WO2010019656A   [0006] 
GB1418809A   [0086] 

Nature   [0073] 
Eur. J. Immun.   [0073] 
Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins   [0085] 
Three genes in the human MHC class III region near the junction with the class II: gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3   [0085] 
RAGE: a single receptor fits multiple ligands   [0085] 
Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB   [0085] 
Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease   [0085] 
Sensing danger--Hsp72 and HMGB1 as candidate signals   [0085] 
Matricellular proteins: from homeostasis to inflammation, cancer, and metastasis   [0085] 
Internalization of the receptor for advanced glycation end products (RAGE) is required to mediate intracellular responses   [0085] 
The receptor for advanced glycation end-products: a complex signaling scenario for a promiscuous receptor   [0085] 
RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis   [0085] 
RAGE signaling sustains inflammation and promotes tumor development   [0085] 
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases   [0085] 
A novel function of the receptor for advanced glycation end-products (RAGE) in association with tumorigenesis and tumor differentiation of HCC   [0085] 
Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response   [0085] 
Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases   [0085] 
RNA interference as an anticancer therapy: a patent perspective   [0085] 
RNA Interference as a Plausible Anticancer Therapeutic Tool   [0085] 
Antibody-Drug Conjugates: Linking Cytotoxic Payloads to Monoclonal Antibodies   [0085] 
Enhanced activity of monomethylauristatin F through monoclonal antibody delivery: effects of linker technology on efficacy and toxicity   [0085] 
Remington's Pharmaceutical Sciences   [0085] 
Pharmazie in unserer Zeit   [0085]